Beers Jessica L, Hebert Mary F, Wang Joanne
Department of Pharmacy, University of Washington, Seattle, WA, USA.
Department of Pharmaceutics, University of Washington, Seattle, WA, USA.
Expert Opin Drug Metab Toxicol. 2025 Apr;21(4):409-428. doi: 10.1080/17425255.2025.2461479. Epub 2025 Feb 7.
Medication use is highly prevalent in breastfeeding persons, posing potential risks for drug exposure to nursing infants. Transporters in the lactating mammary gland carry pharmacological and toxicological significance, as they can mediate the active transfer of drugs and nutrients into breastmilk.
In this narrative review, we searched and compiled current knowledge on the transport of drugs in the human mammary gland from literature indexed in PubMed (current as of 25 October 2024), and clinical evidence demonstrating active transport of drugs into milk is provided. In vitro and in vivo models of the mammary gland are outlined in brief and known drug transporters at the blood-milk barrier and their potential relevance to drug concentrations in milk are described in detail.
Although clinical data show that membrane transporters mediate the transfer of multiple drugs into breast milk, our ability to predict milk concentrations for these drugs is limited. Improving our understanding of the transporter biology and pharmacology in the mammary gland is crucial for developing models to predict drug concentrations in human milk, which will support clinicians and lactating individuals in making rational decisions to balance the benefits of breastfeeding and the risks of drug exposure to infants.
药物使用在哺乳期人群中非常普遍,这给哺乳期婴儿带来了药物暴露的潜在风险。哺乳期乳腺中的转运体具有药理学和毒理学意义,因为它们可以介导药物和营养物质主动转运到母乳中。
在本叙述性综述中,我们从PubMed(截至2024年10月25日)索引的文献中搜索并汇编了关于药物在人乳腺中转运的现有知识,并提供了证明药物主动转运到乳汁中的临床证据。简要概述了乳腺的体外和体内模型,并详细描述了血乳屏障处已知的药物转运体及其与乳汁中药物浓度的潜在相关性。
尽管临床数据表明膜转运体介导多种药物转运到母乳中,但我们预测这些药物乳汁浓度的能力有限。更好地理解乳腺中的转运体生物学和药理学对于开发预测人乳中药物浓度的模型至关重要,这将有助于临床医生和哺乳期人群做出合理决策,以平衡母乳喂养的益处和药物暴露于婴儿的风险。